Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Anricofen

PreclinicalSmall molecule

TThe First Affiliated Hospital of Xinxiang Medical College

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q2 2028

PreclinicalRecruiting

ERCP

NCT07376577

Clinical

Trials by Indication[1]

ERCP1 trial

A Randomized Controlled Trial on the Efficacy and Safety of Anricofen Combined With Ciprofol for Deep Sedation in Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography

Recruiting·TThe First Affiliated Hospital of Xinxiang Medical College·Preclinical·NCT07376577·141 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Anricofen. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Anricofen compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Anricofen. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The First Affiliated Hospital of Xinxiang Medical College company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TThe First Affiliated Hospital of Xinxiang Medical College

Related News